Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name inhaler prescribed for COPD and asthma. Trelegy Ellipta has interactions with some other drugs ...
Some people with chronic obstructive pulmonary disease (COPD) need to use multiple inhaled medicines each day to control their symptoms. Long-acting combination inhalers that contain more than one ...
Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name drug prescribed as a maintenance treatment for asthma and chronic obstructive pulmonary disease ...
Some people with asthma need to use multiple inhaled medicines each day to keep their symptoms under control. The approval of long-acting, combination inhalers that contain more than one medicine is ...
* TRELEGY ELLIPTA ONCE-DAILY SINGLE INHALER TRIPLE THERAPY RECEIVES POSITIVE OPINION FROM CHMP IN EUROPE FOR APPROPRIATE PATIENTS WITH COPD * TRELEGY ELLIPTA ONCE-DAILY SINGLE INHALER TRIPLE THERAPY ...
Edited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/15/2026 at 9:30 PM ET. Details in the imprint. With its once-daily inhaler Trelegy Ellipta, GSK is pushing deeper ...
RadioMedix’s Detectnet (copper Cu 64 dotatate injection) has been approved for the detection of somatostatin receptor‒positive neuroendocrine tumors (NETs) in adult patients during imaging with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results